Suppr超能文献

关于某些系列抗乙型肝炎病毒(HBV)药物的定量构效关系(QSAR)研究。

A QSAR study on some series of anti-hepatitis B virus (HBV) agents.

作者信息

Arora Preet K, Patil Vaishali M, Gupta Satya P

机构信息

Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology, Meerut 250005, India.

出版信息

Bioinformation. 2010 Mar 31;4(9):417-20. doi: 10.6026/97320630004417.

Abstract

A quantitative structure-activity relationship (QSAR) study has been made on some series of anti-hepatitis B virus (HBV) agents, namely, a series of novel bis(L-amino acid) ester prodrugs of 9-[2--(phosphonomethoxy)ethyl]adenine, a similar series of compounds comprising of 2- amino-6-arylthio-9-[2-(phosphonoethoxy)ethyl] purine bis(2,2,2- trifluoroethyl) esters, and a series of 1-isopropylsulfonyl-2-amine benzimidazoles. In each case significant correlations are found between the anti-HBV potencies and some physicochemical and steric properties of the compounds, indicating that for the first two series the activity is controlled by the hydrophobic and the bulk properties of the molecules and, for the third series, the steric and hydrogen bonding properties of compounds are crucial for their anti-HBV potency.

摘要

已对一些系列的抗乙型肝炎病毒(HBV)药物进行了定量构效关系(QSAR)研究,这些药物包括:一系列新型的9-[2-(膦酰甲氧基)乙基]腺嘌呤双(L-氨基酸)酯前药、一系列由2-氨基-6-芳硫基-9-[2-(膦酰乙氧基)乙基]嘌呤双(2,2,2-三氟乙基)酯组成的类似化合物系列,以及一系列1-异丙基磺酰基-2-胺苯并咪唑。在每种情况下,均发现化合物的抗HBV效力与某些物理化学和空间性质之间存在显著相关性,这表明对于前两个系列,活性受分子的疏水性和体积性质控制,而对于第三个系列,化合物的空间和氢键性质对其抗HBV效力至关重要。

相似文献

1
A QSAR study on some series of anti-hepatitis B virus (HBV) agents.
Bioinformation. 2010 Mar 31;4(9):417-20. doi: 10.6026/97320630004417.
4
Design and synthesis of novel bis(L-amino acid) ester prodrugs of 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) with improved anti-HBV activity.
Bioorg Med Chem Lett. 2007 Jan 15;17(2):465-70. doi: 10.1016/j.bmcl.2006.10.021. Epub 2006 Oct 12.
5
Identification of 1-isopropylsulfonyl-2-amine benzimidazoles as a new class of inhibitors of hepatitis B virus.
Eur J Med Chem. 2007 Nov-Dec;42(11-12):1358-64. doi: 10.1016/j.ejmech.2007.03.005. Epub 2007 Mar 31.
8
Expanding the Antiviral Spectrum of 3-Fluoro-2-(phosphonomethoxy)propyl Acyclic Nucleoside Phosphonates: Diamyl Aspartate Amidate Prodrugs.
J Med Chem. 2017 Jul 27;60(14):6220-6238. doi: 10.1021/acs.jmedchem.7b00416. Epub 2017 Jul 6.

引用本文的文献

1
Towards reproducible computational drug discovery.
J Cheminform. 2020 Jan 28;12(1):9. doi: 10.1186/s13321-020-0408-x.
2
AVCpred: an integrated web server for prediction and design of antiviral compounds.
Chem Biol Drug Des. 2017 Jan;89(1):74-83. doi: 10.1111/cbdd.12834. Epub 2016 Sep 9.

本文引用的文献

1
Identification of 1-isopropylsulfonyl-2-amine benzimidazoles as a new class of inhibitors of hepatitis B virus.
Eur J Med Chem. 2007 Nov-Dec;42(11-12):1358-64. doi: 10.1016/j.ejmech.2007.03.005. Epub 2007 Mar 31.
2
Design and synthesis of novel bis(L-amino acid) ester prodrugs of 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) with improved anti-HBV activity.
Bioorg Med Chem Lett. 2007 Jan 15;17(2):465-70. doi: 10.1016/j.bmcl.2006.10.021. Epub 2006 Oct 12.
3
New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA.
J Hepatol. 2005 Mar;42(3):302-8. doi: 10.1016/j.jhep.2004.12.015.
4
Current therapies for chronic hepatitis B virus infection.
Expert Rev Anti Infect Ther. 2004 Oct;2(5):745-60. doi: 10.1586/14789072.2.5.745.
5
Novel treatment options for hepatitis B virus infection.
Curr Opin Investig Drugs. 2004 Feb;5(2):171-8.
6
Antiviral therapy for chronic hepatitis B: a review.
Curr Drug Targets Inflamm Allergy. 2004 Mar;3(1):63-70. doi: 10.2174/1568010043483908.
9
Hepatitis B virus: old, new and future approaches to antiviral treatment.
J Antimicrob Chemother. 2003 Apr;51(4):761-85. doi: 10.1093/jac/dkg163. Epub 2003 Mar 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验